Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y12 receptor. The drug is produced by AstraZeneca.
Applications, Research & Art
Explore the main themes, entities and connections around Ticagrelor. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
people clopidogrel risk stroke acute coronary bleeding effects trial adverse events syndrome cyp3a4 increased evidence used use blood hepatic therapy
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Ticagrelor | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Ticagrelor | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Ticagrelor | ATC code | B01AC24 (WHO) | 1.00 | infobox |
| Ticagrelor | Bioavailability | 36% | 1.00 | infobox |
| Ticagrelor | CAS Number | 274693-27-5 Y | 1.00 | infobox |
| Ticagrelor | ChEMBL | ChEMBL398435 N | 1.00 | infobox |
| Ticagrelor | ChemSpider | 8047109 N | 1.00 | infobox |
| Ticagrelor | CompTox Dashboard (EPA) | DTXSID901009337 | 1.00 | infobox |
| Ticagrelor | DrugBank | DB08816 Y | 1.00 | infobox |
| Ticagrelor | ECHA InfoCard | 100.114.746 | 1.00 | infobox |
| Ticagrelor | Elimination half-life | 7 hrs (ticagrelor), 8.5 hrs (active metabolite AR-C124910XX) | 1.00 | infobox |
| Ticagrelor | Excretion | Bile duct | 1.00 | infobox |
| Ticagrelor | Formula | C23H28F2N6O4S | 1.00 | infobox |
| Ticagrelor | IUPHAR/BPS | 1765 | 1.00 | infobox |
| Ticagrelor | KEGG | D09017 Y | 1.00 | infobox |
| Ticagrelor | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Ticagrelor | Legal status | CA: ℞-only | 1.00 | infobox |
| Ticagrelor | Legal status | US: ℞-only | 1.00 | infobox |
| Ticagrelor | Legal status | EU: Rx-only | 1.00 | infobox |
| Ticagrelor | License data | US DailyMed: Ticagrelor | 1.00 | infobox |
| Ticagrelor | MedlinePlus | a611050 | 1.00 | infobox |
| Ticagrelor | Metabolism | Liver (CYP3A4) | 1.00 | infobox |
| Ticagrelor | Molar mass | 522.57 g·mol−1 | 1.00 | infobox |
| Ticagrelor | Other names | AZD-6140 | 1.00 | infobox |
| Ticagrelor | Pregnancy category | AU: B1 | 1.00 | infobox |
| Ticagrelor | Protein binding | >99.7% | 1.00 | infobox |
| Ticagrelor | PubChem CID | 9871419 | 1.00 | infobox |
| Ticagrelor | Routes of administration | By mouth | 1.00 | infobox |
| Ticagrelor | Trade names | Brilinta, Brilique, others | 1.00 | infobox |
| Ticagrelor | UNII | GLH0314RVC | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.